Tove K Ryman1, Bert B Boyer2, Scarlett E Hopkins2, Jacques Philip2, Beti Thompson3, Shirley A A Beresford1, Kenneth E Thummel4, Melissa A Austin1. 1. a Department of Epidemiology, School of Public Health , University of Washington , Seattle , WA , USA. 2. b Center for Alaska Native Health Research , University of Alaska Fairbanks , Fairbanks , AK , USA. 3. c Department of Health Services , University of Washington , Seattle , WA , USA. 4. d Department of Pharmaceutics , University of Washington , Seattle , WA , USA.
Abstract
OBJECTIVE: The traditional lifestyle of Yup'ik Alaska Native people, including a diet abundant in marine-based foods and physical activity, may be cardio-protective. However, iq'mik, a traditional form of smokeless tobacco used by >50% of Yup'ik adults, could increase cardiometabolic (CM) risk. Our objective was to characterize the associations between iq'mik use and biomarkers of CM status (low-density lipoprotein cholesterol [LDL-C], high-density lipoprotein cholesterol [HDL-C], triglycerides [TG], systolic blood pressure [SBP] and diastolic blood pressure [DBP], glycated hemoglobin [HbA1c], fasting blood glucose [FBG], waist circumference [WC], and body mass index [BMI]). DESIGN: We assessed these associations using data from a cross-sectional sample of Yup'ik adults (n = 874). Current iq'mik use, demographic, and lifestyle data were collected through interviews. Fasting blood samples were collected to measure LDL-C, HDL-C, TG, HbA1c, and FBG. SBP, DBP, WC, and BMI were obtained by physical examination. We characterized the association between current iq'mik use and continuous biomarkers of CM status using multiple approaches, including adjustment for measures of Yup'ik lifestyle and a propensity score. RESULTS: Based on either adjustment method, current iq'mik use was significantly and positively associated with at least 5% higher HDL-C, and significantly associated but in an inverse direction with multiple biomarkers of CM status including 7% lower TG, 0.05% lower HbA1c, 2% lower FBG, 4% lower WC, and 4% lower BMI. Observed associations for LDL-C, SBP, and DBP varied by adjustment method. CONCLUSIONS: This inverse association between iq'mik use and cardiometabolic risk status has not been previously reported. Additional research is needed to replicate these findings and explore physiological mechanisms and/or confounding factors.
OBJECTIVE: The traditional lifestyle of Yup'ik Alaska Native people, including a diet abundant in marine-based foods and physical activity, may be cardio-protective. However, iq'mik, a traditional form of smokeless tobacco used by >50% of Yup'ik adults, could increase cardiometabolic (CM) risk. Our objective was to characterize the associations between iq'mik use and biomarkers of CM status (low-density lipoprotein cholesterol [LDL-C], high-density lipoprotein cholesterol [HDL-C],triglycerides [TG], systolic blood pressure [SBP] and diastolic blood pressure [DBP], glycated hemoglobin [HbA1c],fasting blood glucose [FBG], waist circumference [WC], and body mass index [BMI]). DESIGN: We assessed these associations using data from a cross-sectional sample of Yup'ik adults (n = 874). Current iq'mik use, demographic, and lifestyle data were collected through interviews. Fasting blood samples were collected to measure LDL-C, HDL-C, TG, HbA1c, and FBG. SBP, DBP, WC, and BMI were obtained by physical examination. We characterized the association between current iq'mik use and continuous biomarkers of CM status using multiple approaches, including adjustment for measures of Yup'ik lifestyle and a propensity score. RESULTS: Based on either adjustment method, current iq'mik use was significantly and positively associated with at least 5% higher HDL-C, and significantly associated but in an inverse direction with multiple biomarkers of CM status including 7% lower TG, 0.05% lower HbA1c, 2% lower FBG, 4% lower WC, and 4% lower BMI. Observed associations for LDL-C, SBP, and DBP varied by adjustment method. CONCLUSIONS: This inverse association between iq'mik use and cardiometabolic risk status has not been previously reported. Additional research is needed to replicate these findings and explore physiological mechanisms and/or confounding factors.
Authors: Mariann R Piano; Neal L Benowitz; Garret A Fitzgerald; Susan Corbridge; Janie Heath; Ellen Hahn; Terry F Pechacek; George Howard Journal: Circulation Date: 2010-09-13 Impact factor: 29.690
Authors: David K Espey; Melissa A Jim; Nathaniel Cobb; Michael Bartholomew; Tom Becker; Don Haverkamp; Marcus Plescia Journal: Am J Public Health Date: 2014-04-22 Impact factor: 9.308
Authors: Andrea Bersamin; Christopher Wolsko; Bret R Luick; Bert B Boyer; Cecile Lardon; Scarlett E Hopkins; Judith S Stern; Sheri Zidenberg-Cherr Journal: Ethn Health Date: 2013-01-09 Impact factor: 2.772
Authors: Neal L Benowitz; Caroline C Renner; Anne P Lanier; Rachel F Tyndale; Dorothy K Hatsukami; Bruce Lindgren; Irina Stepanov; Clifford H Watson; Connie S Sosnoff; Peyton Jacob Journal: Cancer Epidemiol Biomarkers Prev Date: 2012-04-06 Impact factor: 4.254
Authors: Christi A Patten; Caroline C Renner; Paul A Decker; Ester O'Campo; Karin Larsen; Carrie Enoch; Kenneth P Offord; Richard D Hurt; Anne Lanier; Judith Kaur Journal: Matern Child Health J Date: 2008-03-14
Authors: Caroline C Renner; Christi A Patten; Carrie Enoch; John Petraitis; Kenneth P Offord; Sarah Angstman; Andrew Garrison; Caroline Nevak; Ivana T Croghan; Richard D Hurt Journal: Prev Med Date: 2004-04 Impact factor: 4.018
Authors: Jacques Philip; Tove K Ryman; Scarlett E Hopkins; Diane M O'Brien; Andrea Bersamin; Jeremy Pomeroy; Kenneth E Thummel; Melissa A Austin; Bert B Boyer; Kirk Dombrowski Journal: PLoS One Date: 2017-11-01 Impact factor: 3.240